These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11529808)

  • 1. The rotavirus vaccine's withdrawal and physicians' trust in vaccine safety mechanisms.
    McPhillips HA; Davis RL; Marcuse EK; Taylor JA
    Arch Pediatr Adolesc Med; 2001 Sep; 155(9):1051-6. PubMed ID: 11529808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Will pediatricians adopt the new rotavirus vaccine?
    Kempe A; Daley MF; Parashar UD; Crane LA; Beaty BL; Stokley S; Barrow J; Babbel C; Dickinson LM; Widdowson MA; Alexander JP; Berman S
    Pediatrics; 2007 Jan; 119(1):1-10. PubMed ID: 17200265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physicians' knowledge and attitudes about rotavirus gastroenteritis and rotavirus vaccine.
    Haupt RM; Isikci O; Kimble WL; Sotos GL; Fu J
    Pediatr Ann; 2006 Jan; 35(1):54-61. PubMed ID: 16466076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intussusception among recipients of rotavirus vaccine: reports to the vaccine adverse event reporting system.
    Zanardi LR; Haber P; Mootrey GT; Niu MT; Wharton M
    Pediatrics; 2001 Jun; 107(6):E97. PubMed ID: 11389295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An analysis of rotavirus vaccine reports to the vaccine adverse event reporting system: more than intussusception alone?
    Haber P; Chen RT; Zanardi LR; Mootrey GT; English R; Braun MM;
    Pediatrics; 2004 Apr; 113(4):e353-9. PubMed ID: 15060267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007.
    Haber P; Patel M; Izurieta HS; Baggs J; Gargiullo P; Weintraub E; Cortese M; Braun MM; Belongia EA; Miller E; Ball R; Iskander J; Parashar UD
    Pediatrics; 2008 Jun; 121(6):1206-12. PubMed ID: 18519491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of administration and attitudes about pneumococcal, Haemophilus influenzae type b and rotavirus vaccines among pediatricians in India: a national survey.
    Gargano LM; Thacker N; Choudhury P; Weiss PS; Pazol K; Bahl S; Jafari HS; Arora M; Orenstein WA; Hughes JM; Omer SB
    Vaccine; 2012 May; 30(24):3541-5. PubMed ID: 22475859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adoption of rotavirus vaccine by U.S. physicians: progress and challenges.
    O'Leary ST; Parashar UD; Crane LA; Allison MA; Stokley S; Beaty BL; Brtnikova M; Hurley LP; Kempe A
    Am J Prev Med; 2013 Jan; 44(1):56-62. PubMed ID: 23253650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A survey of pediatricians on the reintroduction of a rotavirus vaccine.
    Iwamoto M; Saari TN; McMahon SR; Yusuf HR; Massoudi MS; Stevenson JM; Chu SY; Pickering LK
    Pediatrics; 2003 Jul; 112(1 Pt 1):e6-10. PubMed ID: 12837898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adoption of rotavirus vaccination by pediatricians and family medicine physicians in the United States.
    Kempe A; Patel MM; Daley MF; Crane LA; Beaty B; Stokley S; Barrow J; Babbel C; Dickinson LM; Tempte JL; Parashar UD
    Pediatrics; 2009 Nov; 124(5):e809-16. PubMed ID: 19822592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants.
    Shui IM; Baggs J; Patel M; Parashar UD; Rett M; Belongia EA; Hambidge SJ; Glanz JM; Klein NP; Weintraub E
    JAMA; 2012 Feb; 307(6):598-604. PubMed ID: 22318281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
    Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
    MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postmarketing monitoring of intussusception after RotaTeq vaccination--United States, February 1, 2006-February 15, 2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Mar; 56(10):218-22. PubMed ID: 17363890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of postlicensure safety of rotavirus vaccines, with emphasis on intussusception.
    Bines JE; Patel M; Parashar U
    J Infect Dis; 2009 Nov; 200 Suppl 1():S282-90. PubMed ID: 19817611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development, clinical evaluation, and post-licensure impact of RotaTeq, a pentavalent rotavirus vaccine.
    Goveia MG; Ciarlet M; Owen KE; Ranucci CS
    Ann N Y Acad Sci; 2011 Mar; 1222():14-8. PubMed ID: 21434938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rotarix®: vaccine performance 6 years postlicensure.
    O'Ryan M; Lucero Y; Linhares AC
    Expert Rev Vaccines; 2011 Dec; 10(12):1645-59. PubMed ID: 22085167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rotavirus vaccination and intussusception - Science, surveillance, and safety: A review of evidence and recommendations for future research priorities in low and middle income countries.
    Yen C; Healy K; Tate JE; Parashar UD; Bines J; Neuzil K; Santosham M; Steele AD
    Hum Vaccin Immunother; 2016 Oct; 12(10):2580-2589. PubMed ID: 27322835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse events and vaccination-the lack of power and predictability of infrequent events in pre-licensure study.
    Jacobson RM; Adegbenro A; Pankratz VS; Poland GA
    Vaccine; 2001 Mar; 19(17-19):2428-33. PubMed ID: 11257373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicians' confidence in vaccine safety studies.
    O'Leary ST; Allison MA; Stokley S; Crane LA; Hurley LP; Beaty B; Kempe A
    Prev Med; 2013 Mar; 56(3-4):231-3. PubMed ID: 23333206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ensuring the optimal safety of licensed vaccines: a perspective of the vaccine research, development, and manufacturing companies.
    Kanesa-thasan N; Shaw A; Stoddard JJ; Vernon TM
    Pediatrics; 2011 May; 127 Suppl 1():S16-22. PubMed ID: 21502248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.